Adapalene Patent Expiration
Adapalene is Used for treating acne vulgaris. It was first introduced by Galderma Laboratories Lp
Adapalene Patents
Given below is the list of patents protecting Adapalene, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Differin | US7998467 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers | May 31, 2028 | Galderma Labs Lp |
| Differin | US8435502 | Cosmetic/dermatological compositions comprising naphtholic acid compounds and polyurethane polymers | Sep 15, 2026 | Galderma Labs Lp |
| Differin | US8709392 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers | Sep 15, 2026 | Galderma Labs Lp |
| Differin | US7579377 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Feb 23, 2025
(Expired) | Galderma Labs Lp |
| Differin | US7737181 | Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Aug 29, 2024
(Expired) | Galderma Labs Lp |
| Differin | US7834060 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US7838558 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US7868044 | Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
| Differin | US8703820 | Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
Mar 12, 2023
(Expired) | Galderma Labs Lp |
Adapalene's Family Patents
Explore Our Curated Drug Screens
Adapalene Generic API Manufacturers
Several generic applications have been filed for Adapalene. The first generic version for Adapalene was by P And L Development Llc and was approved on Jun 2, 2010. And the latest generic version is by Taro Pharmaceuticals Inc and was approved on Jan 14, 2022.
Given below is the list of companies who have filed for Adapalene generic, along with the locations of their manufacturing plants worldwide.
1. ACTAVIS MID ATLANTIC
Actavis Mid Atlantic Llc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Actavis Mid Atlantic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Oct 27, 2014 |
2. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Jun 18, 2020 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
3. CALL INC
Call Inc Dba Rochester Pharmaceuticals has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Call Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | solution | Prescription | TOPICAL | AB | Sep 23, 2016 |
4. ENCUBE ETHICALS
Encube Ethicals Pvt Ltd has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Encube Ethicals.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Jun 14, 2012 |
Manufacturing Plant Locations New
Encube Ethicals's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Encube Ethicals as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
5. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | cream | Prescription | TOPICAL | AB | Jun 30, 2010 |
6. GLENMARK GENERICS
Glenmark Generics Inc Usa has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Glenmark Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jul 9, 2019 |
Manufacturing Plant Locations New
Glenmark Generics's manufacturing plants are situated in 1 country - Argentina. Given below are the details of these plant locations as well as the firm names of Glenmark Generics as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Argentina |
| |||
7. GLENMARK PHARMS INC
Glenmark Pharmaceuticals Inc Usa has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jul 1, 2010 |
8. P AND L
P And L Development Llc has filed for 1 generic for Adapalene. Given below are the details of the strengths of this generic introduced by P And L.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jun 2, 2010 |
9. TARO
Taro Pharmaceuticals Inc has filed for 2 different strengths of generic version for Adapalene. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3% | gel | Prescription | TOPICAL | AB | Jun 23, 2016 |
| 0.1% | gel | Over the counter | TOPICAL | N/A | Jan 14, 2022 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||